Paul Quinlan | General Counsel, Chief Compliance Officer & Corporate Secretary |
Sujal Shah | President, CEO & Director |
Charles McWherter | SVP & Chief Scientific Officer |
Daniel Menold | VP, Finance |
Lewis Stuart | Chief Commercial Officer |
Dennis Kim | Chief Medical Officer |
Yasmeen Rahimi | Piper Sandler & Co. |
Steven Seedhouse | Raymond James & Associates |
Thomas Yip | H.C. Wainwright & Co. |
Mayank Mamtani | B. Riley Securities |
Cory Jubinville | LifeSci Capital |
Michael Kratky | SVB Securities |
Kristen Kluska | Cantor Fitzgerald & Co. |
Good day, ladies and gentlemen, and welcome to the CymaBay Second Quarter 2020 Financial Results and Business Update Conference Call. [Operator Instructions]. Please be advised that the call will be recorded at the company's request. It is also being webcast live on the Investors section at the CymaBay website at www.cymabay.com.
Now I would like to turn the call over to Mr.